Sort by
Search results
Prekallikrein Deficient Plasma
For any in vitro protocol or research study where a source of human prekallikrein deficient plasma is required.
PAI-1 Deficient Plasma
For any in vitro protocol or research study where a source of human PAI-1 deficient plasma is required.
Plasminogen Deficient Plasma
For any in vitro protocol or research study where a source of human plasminogen deficient plasma is required.
Apolipoprotein H (β2-Glycoprotein-I) Deficient Plasma
For any in vitro protocol or research study where a source of human APO-H deficient plasma is required.
α2-Antiplasmin Deficient Plasma
For any in vitro protocol or research study where a source of human α2-antiplasmin deficient plasma is required.
ZYMUTEST tPA Antigen
Assay of tPA:Ag in clinical samples, as a disease marker. Assay of tPA:Ag in thrombolysis with recombinant tPA drugs. Assay of tPA:Ag as a cardiovascular disease marker.
ZYMUPHEN tPA Activity
Assay proposed for the measurement of tPA activity in research applications.
ZYMUTEST TAFI (Total) Antigen
High TAFI Ag concentrations involve a hypofibrinolytic status, which can induce an elevated risk of thrombosis. Measurement of TAFI Ag on plasma in order to diagnose a risk of a hypofibrinolysis resulting from an excess of TAFI.
ZYMUTEST Anti-Protein Z, IgM
Assay proposed for the measurement of IgM isotype auto antibodies targeted to protein Z in research applications.
ZYMUTEST Anti-Protein Z, IgG
Assay proposed for the measurement of IgG isotype auto antibodies targeted to protein Z in research applications.